Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.770
-0.050 (-1.31%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Cytek Biosciences Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Cytek Biosciences stock have an average target of 7.00, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts an increase of 85.68% from the current stock price of 3.77.

Analyst Consensus: Buy
Target Low Average Median High
Price $6.00 $7.00 $8.00 $8.00
Change +59.15% +85.68% +112.20% +112.20%
* Price targets were last updated on Mar 19, 2025.

Analyst Ratings

The average analyst rating for Cytek Biosciences stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Nov '24Dec '24Jan '25Feb '25Mar '25Apr '25
Strong Buy 111100
Buy 222222
Hold 000000
Sell 000000
Strong Sell 000000
Total 333322

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Stephens & Co.
Stephens & Co.
Buy
Reiterates
$6
Buy Reiterates $6 +59.15% Mar 19, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$8.5$8
Buy Maintains $8.5$8 +112.20% Mar 4, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$8$8.5
Buy Maintains $8$8.5 +125.46% Nov 11, 2024
Piper Sandler
Piper Sandler
Buy
Maintains
$8.5$8
Buy Maintains $8.5$8 +112.20% Aug 13, 2024
Piper Sandler
Piper Sandler
Buy
Maintains
$10$8.5
Buy Maintains $10$8.5 +125.46% May 13, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
208.52M
from 200.45M
Increased by 4.02%
Revenue Next Year
226.19M
from 208.52M
Increased by 8.47%
EPS This Year
-0.05
from -0.05
EPS Next Year
-0.00
from -0.05
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
92.84M127.95M164.04M193.02M200.45M208.52M226.19M267.54M
Revenue Growth
60.39%37.82%28.20%17.67%3.85%4.02%8.47%18.28%
EPS
0.100.000.02-0.09-0.05-0.05-0.000.08
EPS Growth
--99.36%2,906.28%-----
Forward PE
-------46.20
No. Analysts
-----886
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 218.4M 244.6M 303.1M
Avg 208.5M 226.2M 267.5M
Low 194.0M 199.6M 227.4M

Revenue Growth

Revenue Growth 202520262027
High
8.9%
17.3%
34.0%
Avg
4.0%
8.5%
18.3%
Low
-3.2%
-4.3%
0.5%

EPS Forecast

EPS 202520262027
High -0.02 0.13 0.19
Avg -0.05 -0.00 0.08
Low -0.07 -0.07 0.01

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.